13F HOLDINGS REPORT
Aisling Capital Management LP
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0001766721-25-000004
Total Value
$359.7M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BridgeBio Pharma Inc. (BBIO) | BBIO | 6,068,125 | $262.0M | 72.85% |
| 2 | Verona Pharma plc (VRNA) | 925050106 | 615,352 | $58.2M | 16.18% |
| 3 | Syndax Pharmaceuticals, Inc. (SNDX) | SNDX | 1,316,806 | $12.3M | 3.43% |
| 4 | Monte Rosa Therapeutics Inc (GLUE) | GLUE | 1,472,331 | $6.6M | 1.85% |
| 5 | Bicara Therapeutics Inc. (BCAX) | BCAX | 568,919 | $5.3M | 1.47% |
| 6 | Nuvation Bio Inc. (NUVB) | NUVB | 2,541,009 | $5.0M | 1.38% |
| 7 | Biomea Fusion Inc (BMEA) | BMEA | 2,048,757 | $3.7M | 1.03% |
| 8 | Compass Pathways Plc (CMPS) | CMPS | 1,198,418 | $3.4M | 0.93% |
| 9 | Elevation Oncology Inc (ELEV) | 28623U101 | 2,834,910 | $1.0M | 0.29% |
| 10 | CalciMedica, Inc. (CALC) | CALC | 521,114 | $833,782 | 0.23% |
| 11 | Aclaris Therapeutics Inc (ACRS) | ACRS | 434,455 | $616,926 | 0.17% |
| 12 | Marker Therapeutics, Inc. (MRKR) | MRKR | 325,370 | $497,816 | 0.14% |
| 13 | OnKure Therapeutics, Inc. (OKUR) | OKUR | 88,607 | $211,771 | 0.06% |